FDA 483 - Occlutech International AB - May 05, 2022

Occlutech International AB, a medical device manufacturer in Helsingborg, Sweden, was cited for four observations during an FDA inspection. The firm failed to establish adequate procedures for process controls, complaint handling, incoming product acceptance, and device history records. These deficiencies indicate a need for improved quality system documentation and adherence to regulatory requirements.